BlossomHill Therapeutics, Inc. (BLSM)

BlossomHill Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BlossomHill Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	116	136.68	100.15
Cash & Cash Equivalents	116	136.68	100.15
Cash Growth	-	36.48%	-
Other Current Assets	3.72	2.14	4.03
Total Current Assets	119.72	138.83	104.17
Property, Plant & Equipment	-	1.73	1.1
Goodwill and Intangibles	-	19.92	0.49
Other Long-Term Assets	-	2.5	1.02
Total Long-Term Assets	-	24.14	2.6
Total Assets	-	162.97	106.78
Accounts Payable	-	2.31	0.85
Current Debt	-	0.01	0.53
Other Current Liabilities	16.18	13.16	5.4
Total Current Liabilities	16.18	15.48	6.77
Long-Term Debt	-	22.39	-
Total Long-Term Liabilities	-	22.39	0
Total Liabilities	-	37.87	6.77
Total Debt	23.02	22.4	0.53
Debt Growth	-	4166.29%	-
Retained Earnings	-	-135.03	-74.47
Shareholders' Equity	-152.12	-131.73	-72.88
Net Cash (Debt)	92.98	114.28	99.62
Net Cash (Debt) Growth	-	14.72%	-
Working Capital	123.35	123.35	97.4